Page last updated: 2024-12-06

5-dimethylaminonaphthalene-1-sulfonamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID65077
CHEMBL ID119489
SCHEMBL ID108421
MeSH IDM0041076

Synonyms (48)

Synonym
OPREA1_628153
STK367047
5-(dimethylamino)naphthalene-1-sulfonamide
5-(dimethylamino)-1-naphthalenesulfonamide
dansylamide
DB02866
1OKL
5-(dimethylamino)-1-naphthalenesulfonamide, 99%
tynbfjjkzptrks-uhfffaoysa-
inchi=1/c12h14n2o2s/c1-14(2)11-7-3-6-10-9(11)5-4-8-12(10)17(13,15)16/h3-8h,1-2h3,(h2,13,15,16)
1431-39-6
CHEMBL119489
5-dimethylaminonaphthalene-1-sulfonamide
D1507
AKOS003242506
A808021
5-dimethylamino-1-naphthalenesulfonamide
einecs 215-854-1
unii-zuz5s5875e
5-(dimethylamino)naphthalene-1-sulphonamide
1-dimethylaminonaphthalene-5-sulfonamide
zuz5s5875e ,
dansyl-1-sulfonamide
dansyl amide
BP-12687
FT-0624411
SCHEMBL108421
bdbm11402
5-dimethylamino-1-naphthalenesulphonamide
5-(dimethylamino)-1-naphthylsulfonamide
5-dimethylamino-1-naphthalene sulfonamide
1-naphthalenesulfonamide, 5-(dimethylamino)-
5-dimethylamino-1-naphthylsulfonamid
DTXSID70162306
mfcd00004000
5-(dimethylamino)-1-naphthalenesulfonamide, for fluorescence, >=98.5% (tlc)
Q4154890
HY-118562
CS-0067480
1-(dimethylamino)-5-naphthalenesulfonamide
D5405
dansylamide [for albumin binding assay]
T70280
dansylamide [for fluorometry]
AS-56325
BAA43139
EN300-372001
Z275140824
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Carbonic Anhydrase IiHomo sapiens (human)Kd0.93000.93000.93000.9300AID977611
Carbonic anhydrase 2Homo sapiens (human)Kd93.00000.00000.41575.5500AID47910
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (12)

Processvia Protein(s)Taxonomy
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID47910Dissociation constant was reported against Carbonic anhydrase II2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation.
AID27788Calculated partition coefficient (clogP) (MlogP)2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation.
AID1811Experimentally measured binding affinity data derived from PDB1996The Journal of biological chemistry, Jan-12, Volume: 271, Issue:2
Unexpected binding mode of the sulfonamide fluorophore 5-dimethylamino-1-naphthalene sulfonamide to human carbonic anhydrase II. Implications for the development of a zinc biosensor.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1996The Journal of biological chemistry, Jan-12, Volume: 271, Issue:2
Unexpected binding mode of the sulfonamide fluorophore 5-dimethylamino-1-naphthalene sulfonamide to human carbonic anhydrase II. Implications for the development of a zinc biosensor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.45)18.7374
1990's21 (38.18)18.2507
2000's16 (29.09)29.6817
2010's13 (23.64)24.3611
2020's2 (3.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.11 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other56 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]